This paper examines various estimators of average treatment effects (ATE) and their sensitivity to double model misspecification under the assumption of unconfoundedness. The consistency of these estimators of ATE is generally associated with the specification of two models: one model for the potential outcome and the other one for the probability of being assigned to the treatment group (i.e., the propensity score). It is unknown which estimator of ATE performs systematically better when the model for the outcome and the model for the propensity score are both misspecified. In this study, we compare the six estimators of ATE under double misspecification in a simulation study and find which estimators yield the smallest errors. We find tha...
There is an increasing interest in the use of propensity score (PS) methods for confounding control,...
Abstract Background In observational studies, double robust or multiply robust (MR) approaches provi...
Statistical approaches for estimating treatment effectiveness commonly model the endpoint, or the pr...
This paper examines various estimators of average treatment effects (ATE) and their sensitivity to d...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
The final, definitive version of this paper has been published in Statistical Methods in Medical Res...
In this paper, we discuss an estimator for average treatment effects (ATEs) known as the augmented i...
Objective As covariates are not always adequately balanced after propensity score matching and doubl...
In many observational studies, analysts estimate treatment effects using propensity scores, e.g. by ...
Comparative effectiveness research often relies on large administrative data, such as claims data. M...
Estimating treatment effects with observational data requires adjustment for confounding at the anal...
In many observational studies, analysts estimate treatment effects using propensity scores, e.g., by...
There is an increasing interest in the use of propensity score (PS) methods for confounding control,...
Abstract Background In observational studies, double robust or multiply robust (MR) approaches provi...
Statistical approaches for estimating treatment effectiveness commonly model the endpoint, or the pr...
This paper examines various estimators of average treatment effects (ATE) and their sensitivity to d...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
Commonly used semi-parametric estimators of causal effects, specify parametric models for the prope...
The final, definitive version of this paper has been published in Statistical Methods in Medical Res...
In this paper, we discuss an estimator for average treatment effects (ATEs) known as the augmented i...
Objective As covariates are not always adequately balanced after propensity score matching and doubl...
In many observational studies, analysts estimate treatment effects using propensity scores, e.g. by ...
Comparative effectiveness research often relies on large administrative data, such as claims data. M...
Estimating treatment effects with observational data requires adjustment for confounding at the anal...
In many observational studies, analysts estimate treatment effects using propensity scores, e.g., by...
There is an increasing interest in the use of propensity score (PS) methods for confounding control,...
Abstract Background In observational studies, double robust or multiply robust (MR) approaches provi...
Statistical approaches for estimating treatment effectiveness commonly model the endpoint, or the pr...